Dr. Sushama R. Chaphalkar

PhD in Microbiology

Biotechnology, Microbiology

Dr. Sushama R. Chaphalkar is a senior researcher and academician based in Pune, India. She holds a PhD in Microbiology and comes with vast experience in research and education in Biotechnology. In her illustrious career spanning three decades and a half, she held prominent leadership positions in academia and industry. As the Founder-Director of a renowned Biotechnology institute, she worked extensively on high-end research projects of industrial significance, fostering a stronger bond between industry and academia.

Dr. Chaphalkar is passionate about sustainable development through Biotechnology and brought about significant agrarian development in parts of rural Maharashtra, through her 11-year-long project titled “Biovillage,” which involved need-based research as well as training of the rural population, especially farmers. When she is not working or mentoring students, she finds joy in avid reading, music, gardening, culinary adventures, and exploring new destinations through travel.

See less

Articles from Sushama R.

Green environments linked to lower depression and anxiety risk, study finds

Comprehensive study found that prolonged exposure to green environments is associated with a reduced risk of developing depression and anxiety, suggesting air pollution as a significant pathway for this protective effect.

31 Mar 2024

Study reveals obesity's link to increased risk of multiple sclerosis and ischemic stroke

The genetic relationship between body mass index (BMI) and multiple neurological diseases.

29 Mar 2024

How do acetylsalicylic acid and warfarin interact with various nutrients?

45 drug-nutrient interactions (DNIs) that modify micro-nutritional status, particularly focusing on how acetylsalicylic acid (ASA) and warfarin may affect patients through various mechanisms.

28 Mar 2024

AI's health misinformation challenge: Study calls for stronger safeguards and transparency

Study uncovers that current safeguards against health disinformation in large language models (LLMs) are applied inconsistently, and AI developers lack transparency in their risk mitigation strategies, highlighting a crucial need for more stringent regulation and comprehensive auditing processes.

24 Mar 2024

Rising antimicrobial resistance in STIs: A call for global action

Review delves into the rising challenge of antimicrobial resistance in sexually transmitted infections, underscoring the need for innovative treatments and the critical role of global surveillance in managing diseases like gonorrhea and syphilis.

21 Mar 2024

Middle age: A critical turning point for brain health and cognition

Review emphasizes the significance of midlife for cognitive trajectories and brain health, advocating for research models that capture non-linear changes to better understand the unique processes occurring during this period.

20 Mar 2024

Milk ladder approach offers hope for children with cow's milk allergy

Researchers review milk ladder use for managing cow's milk allergy in children, emphasizing its potential in safely introducing cow's milk to induce tolerance and the need for standardization and further research.

19 Mar 2024

Measles outbreak in Illinois underscores critical need for vaccination

Study reports a measles outbreak among five unvaccinated children in Illinois, highlighting the disease's high transmissibility even among those not in direct contact, underscoring the critical importance of vaccination.

17 Mar 2024

Innovative approaches needed to overcome health system barriers in malaria vaccination

The current literature to investigate the challenges malaria vaccination faced in reaching high-risk children.

15 Mar 2024

Δ-8-Tetrahydrocannabinol use among US teens climbs in states without regulation

Adolescent Δ8-THC use is notably high in the US, particularly in states without Δ8-THC regulations or marijuana legalization, emphasizing the need for enhanced policy and public health initiatives.

13 Mar 2024